Akash Makkar is a Cardiology physician affiliated with Creighton University. OpenAlex indexes 42 publications with 729 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2929 E Camelback Rd Ste 116
Phoenix, AZ 850164425
Telephone
602-698-5820Provider last certified this registry record 13 Nov 2025.
Industry payments
41 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202588 payments$43,845openpaymentsdata.cms.gov ↗
- Boston Scientific CorporationProgram year2025118 payments$15,272openpaymentsdata.cms.gov ↗
- Biosense Webster, Inc.Program year202550 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
72.8%Beta blocker20.5%Metoprolol Succinate51%Carvedilol18%Sotalol15%Metoprolol Tartrate11%Atenolol4%Nebivolol Hcl1%Part D<11 patientsAngiotensin receptor blocker (ARB)7.2%Losartan Potassium40%Telmisartan38%Valsartan15%Losartan-Hydrochlorothiazide6%Part D<11 patients+ 19 more classes in this area
Blood & clotting
15.6%Factor Xa inhibitor10.1%Eliquis92%Xarelto8%Part D≥159 patientsP2Y12 inhibitor4.5%Clopidogrel100%Part D≥117 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.9%Proton pump inhibitor2.2%Pantoprazole Sodium100%Part D≥98 patientsPotassium supplement1.1%Potassium Chloride100%Part D≥27 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-A-16322-ACC OPTIMIZING DEVICE IMPLANTATION: VANCOMYCIN POWDER AS A COST-EFFECTIVE AND SAFE SUBSTITUTE FOR ANTIBIOTIC POUCHES
Journal of the American College of Cardiology
2026 - Early Outcomes With a Next-Generation Dual-Seal Left Atrial Appendage Occluder
JACC. Clinical electrophysiology
2026 - 1-Year Real-World Outcomes With the Amulet Occluder From the EMERGE LAA Postapproval Study
JACC: Cardiovascular Interventions
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Beart, MD
Creighton University
Alan Thorson, MD
Creighton University
Aryan Mooss, MD
Creighton University
Ross Bremner, MD
Creighton University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”